Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study.

Trial Profile

Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Breast cancer; Non-small cell lung cancer; Prostate cancer; Tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 17 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top